key: cord-1017609-t8r1wloq authors: Godoy, Ivan R B; Rodrigues, Tatiane Cantarelli; Skaf, Abdalla title: Myositis ossificans following COVID-19 vaccination date: 2021-06-09 journal: QJM DOI: 10.1093/qjmed/hcab161 sha: 14c226480b0c42196b32477cb5955ac28904199c doc_id: 1017609 cord_uid: t8r1wloq nan Vaccination injection site adverse reactions are common and usually are represented by transitory pain and edema. We present a case of an intramuscular inflammatory nodule related to myositis ossificans following COVID-19 vaccination, and focus on the imaging findings to differentiate with other diagnosis such as muscle edema, abscess and tumors. 4, 5 . In this report we did not performed a muscle biopsy and the temporal link between symptoms and vaccination procedure suggests diagnosis of COVID-19 vaccine-related myositis ossificans as the cause of symptoms. We considered that in addition to minor muscle injury at the site of injection, toxic myopathy may also 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Risk of bursitis and other injuries and dysfunctions of the shoulder following vaccinations COVID-19 vaccine-related myositis Subacromialsubdeltoid bursitis following COVID-19 vaccination: a case of shoulder injury related to vaccine administration (SIRVA) Drug-related myopathies of which the clinician should be aware Toxic and drug-induced myopathies Neuromuscular presentations in patients with COVID-19